InsideArbitrage Event Driven Monitor – October 6, 2023

Subscribe to receive our Event Driven Monitor by email every morning before the market opens.

Merger Arbitrage

1. ORTX: Orchard Therapeutics to be acquired by Kyowa Kirin Co., Ltd. for $387.4 million. Upon completion of the merger, shareholders of Orchard Therapeutics will receive $16.00 per ADS in cash. Orchard shareholders will also hold an additional contingent value right (CVR) of $1.00 per ADS.
2. SP: SP Plus Corporation to be acquired by Metropolis Technologies for $1.9 billion or $54 per share in cash.
3. ATVI: Seeking Alpha summarized a CTFN report that the UK may make a decision on its review of the Microsoft (MSFT) deal as soon as next week. According to the report, the UK CMA is on target to deliver its decision on the acquisition of Activision (ATVI) before the October 18 deadline.

Only plus or premium subscribers can access this post. Subscribe today.